As Silas Croft finished his sanctimonious speech, a hush fell over the room. His gaze swept over the committee members, a subtle challenge in his eyes, as if daring anyone to question his version of events. Mr. Chen looked at me, then at Dr. Sharma.
“Dr. Hansen, Dr. Sharma, you may now present your response to the allegations,” Mr. Chen announced, his voice formal.
Before I could even open my mouth, Dr. Sharma leaned forward, her composure unwavering. “Mr. Chen, with due respect to Mr. Croft’s statement, we request to present our findings first. We believe they offer a crucial context to the allegations against Dr. Hansen.”
Silas Croft’s faint smirk faltered, replaced by a flicker of irritation. He clearly expected me to be on the defensive, to crumble under the weight of his accusations. Dr. Sharma’s interruption was an unexpected maneuver, a subtle act of defiance that visibly unsettled him.
Mr. Chen hesitated, glancing at Croft. “Mr. Croft, do you have an objection to Dr. Sharma presenting first?”
Croft regained his composure quickly. “No, Mr. Chen. I welcome transparency. Let them present whatever they believe is relevant.” His voice was laced with a patronizing tone, still confident in his control of the narrative. This was a mistake on his part, born of arrogance.
“Very well,” Mr. Chen said, nodding to Dr. Sharma. “You may proceed, Dr. Sharma.”
Dr. Sharma rose, her movements deliberate and authoritative. She walked to a projector screen at the side of the room, connecting her laptop. The committee members, their earlier impartiality now tinged with genuine curiosity, leaned forward. Silas Croft, however, retained his casual posture, a picture of feigned indifference.
“Thank you, Mr. Chen,” Dr. Sharma began, her voice clear and strong, commanding the attention of the room. “The allegations against Dr. Hansen stem from her report on a discrepancy within the Croft Foundation’s Cardiac Innovation Grant.”
She paused, making eye contact with each committee member. “We assert that Dr. Hansen’s actions were not only professionally appropriate but ethically imperative. Her ‘disruptive investigation’ actually unearthed a pattern of severe financial impropriety that spans years and impacts the very integrity of this institution’s research.”
Silas Croft stiffened, his feigned nonchalance beginning to crack. His eyes narrowed, a hint of genuine concern now replacing his earlier smugness. This was the specific, personal cruelty of his composure breaking.
Dr. Sharma clicked a button, and the screen behind her lit up. Projected was a meticulously compiled ledger, filled with rows of dates, transactions, and account names. It was the summary from Ms. Davies, authenticated by Dr. Carter’s expert testimony, which he had provided to Ms. Davies under strict confidentiality, without breaking his NDA.
“This is an authenticated internal financial ledger from the Croft Foundation,” Dr. Sharma announced, her voice resonating with authority. “Obtained through forensic analysis of publicly available corporate filings, guided by an expert consultant familiar with the Foundation’s past practices.” She did not name Dr. Carter directly, protecting his identity while leveraging his information.
The committee members murmured, their heads turning to Silas Croft, who was now visibly paler. The projected ledger was clear, damning. It highlighted a series of transfers from the Croft Foundation to “Apex Innovations Holdings LLC,” then from Apex Innovations to “Evergreen Properties Development Group.”
“As you can see,” Dr. Sharma continued, pointing a laser pointer at specific lines, “this ledger clearly shows a pattern of funds being diverted. Specifically, a total of **£42,000** was consistently routed from the grant money intended for medical research.”
My breath caught in my throat. The specific number. The exact amount Ms. Davies had uncovered. It was now laid bare for the entire committee to see. The specific, personal cruelty of this financial theft, quantified and undeniable.
“These funds,” Dr. Sharma explained, her voice hardening, “were not used for ‘administrative overhead’ or for any legitimate research purpose. They were diverted into Evergreen Properties Development Group, a personal shell company controlled directly by Mr. Silas Croft for a failed real estate venture.”
A gasp rippled through the room. The sheer audacity of it, projected for all to see, was shocking. Silas Croft, a prominent benefactor, was exposed as having pilfered research funds for his own personal, failing projects. His face was now a mask of disbelief and dawning horror.
“Dr. Hansen’s original query, Mr. Chen, had inadvertently pointed to this exact, specific amount,” Dr. Sharma concluded, turning to face the chairman. “She didn’t breach confidentiality; she uncovered a systematic fraud.”
The silence in the room was deafening, punctuated only by the soft hum of the projector. All eyes were now on Silas Croft, his aura of calm confidence completely shattered. He looked like a man who had just seen a ghost, his face a shade of ashen gray. The specific layers of the climax were beginning to unfold.
+ There are no comments
Add yours